In 2023, the value of re-imported antibiotics to Italy stood at 140 million USD. From 2024 to 2028, forecasts show a steady increase: 2024 at 149.94 million USD, 2025 at 158.2 million USD, 2026 at 166.29 million USD, 2027 at 174.22 million USD, and 2028 at 181.99 million USD. From 2023 to 2024, there is a 7.1% increase; 2025 sees a 5.5% rise; 2026 records a 5.1% growth; a 4.8% increase in 2027; and 4.4% up in 2028. The compound annual growth rate (CAGR) from 2024 to 2028 stands at approximately 5.7%.
Future trends to watch for:
- Increased pharmaceutical demand driven by healthcare developments.
- Regulations affecting antibiotic imports.
- Shifts in global supply chain dynamics impacting re-import costs.